Event

Back to all short courses

Digital Real-World Evidence Generation Approaches in Rare Diseases and Oncology (Virtual)

LEVEL: Introductory
TRACK: Real World Data & Information Systems 
LENGTH: 4 Hours | Course runs 2 consecutive days, 2 hours each day
 
Register Here

Wednesday, 7 December 2022 | Course runs 2 consecutive days, 2 hours per day
10:00AM–12:00PM Eastern Standard Time (EST)
15:00PM–17:00PM Coordinated Universal Time (UTC)
16:00PM–18:00PM Central European Time (CET)

Thursday, 8 December 2022 | Course runs 2 consecutive days, 2 hours per day
10:00AM–12:00PM Eastern Standard Time (EST)
15:00PM–17:00PM Coordinated Universal Time (UTC)
16:00PM–18:00PM Central European Time (CET)

Click for time zone conversion

DESCRIPTION

This course is designed to provide a good understanding of how to plan and undertake real-world evidence (RWE) studies to collect patient-level data through a digital app and across different countries. During this course, the benefits and challenges of developing digital "bring your own device" (BYOD) apps to collect PRO data will be discussed and analyzed. The focus of the course will be on rare diseases and oncology, and specific case studies will be presented. The methods of analysis of such datasets, as well as their value and use to support HEOR/HTA strategies will also be discussed. The course is open to all and no specific prior experience is required, apart from a basic level of understanding of RWE.

FACULTY MEMBERS

Mark Larkin, MA, PhD
CEO & Founder
Vitaccess, Ltd.
Oxford, UK

Casey Quinn, PhD
Chief Research Officer
Vitaccess, Ltd.
Oxford, UK

Catherine Bottomley, PhD, MPharm
Director, Patient Centered Outcomes Director
Vitaccess, Ltd.
Oxford, UK

Basic Schedule:
Class Time: 2 hours daily